Dr Drew Provan

Senior Lecturer in Haematology, Barts and The London School of Medicine and Dentistry, London, and Editor, ABC of Clinical Haematology

Drew Provan is a general haematologist with a specific interest in immunohaematology. He is currently Senior Lecturer in Haematology at Bart's & The London School of Medicine and Dentistry. He studied molecular genetics at Leicester University before studying medicine. After junior medical posts in Scotland, Nottingham and Yorkshire, in 1993 he went to the Dana-Farber Cancer Institute in Boston, on an American travelling fellowship awarded by the Medical Research Council. He took up the post of consultant haematologist in Southampton in 1995, and moved to Barts & The London in 2000. He enjoys writing and editing and has been involved in the production of a number of books, including MRCP and MRCPath examination books, in addition to Molecular Haematology (Blackwell Science), Oxford Handbook of Clinical Haematology and Oxford Handbook of Clinical & Laboratory Investigation, and the ABC of Clinical Haematology (BMJ books).

Dr Chris McNamara

Consultant Haematologist, The Royal Free Hospital, London

Dr Chris McNamara is a consultant haematologist with an interest in lymphoma and laboratory diagnostics. He is particularly interested in the interface between the haematology laboratory and the patient and how improvements in the way laboratories operate may improve the quality of care provided.

Professor Jamie Cavenagh

Clinical Lead in Haemato-Oncology, Barts and the London NHS Trust, London

Professor Jamie Cavenagh qualified MB BS in 1985 from St Marys Hospital Medical School, London. He trained in clinical haematology at St Georges Hospital, The Royal Marsden Hospital and Barts and The London. He was a Leukaemia Research Fund Scientific Training Fellow from 1992-1994. He is the chairman of the UK Myeloma Forum. He is the author of over 100 peer-reviewed papers, reviews and book chapters. He has a major interest in conducting clinical research into new therapies for haematological cancers.

Dr Anna Godfrey

Clinical Research Fellow, University of Cambridge and Addenbrooke's Hospital, Cambridge

Anna Godfrey is a clinical research fellow at the Department of Haematology, University of Cambridge, and is in the final year of her PhD with Professor Tony Green. Her research interests focus on the JAK2-positive myeloproliferative neoplasms, especially the factors that contribute to the phenotypes of polycythaemia vera and essential thrombocythemia. She participates in meetings of the NCRI subgroup for MPNs and is involved in the running of the PT-1 trial. Through her work at the Addenbrooke’s Hospital MPN clinic, she is also sub-investigator for the Comfort II trial and will soon be recruiting patients for the MAJIC trial.

Professor David Linch

Professor of Haematology and Head of the Department of Haematology, University College London

Professor David Linch is head of the department of haematology and chairman of the Cancer Research UK Cancer Centre at UCL. He is a founding member of the Academy of Medical Sciences. Professor Linch has been chairman of the National Cancer Research Institute lymphoma clinical studies group and is president of the Lymphoma Association.

Dr David Keeling

Consultant Haematologist, Oxford University Hospitals

David Keeling is a consultant at the Oxford Haemophilia and Thrombosis Centre, which contains a large comprehensive care unit for haemophilia, treating children and adults, an outpatient department for the diagnosis and treatment of deep vein thrombosis and an anticoagulant service. He is secretary to the United Kingdom Haemophilia Centre Doctors' Organisation, chair of the haemostasis and thrombosis task force of the British Committee for Standards in Haematology, a member of the current NICE venous thromboembolism guideline development group and a member of the coagulation steering committee of the UK National External Quality Assessment Scheme.

Professor Beverley Hunt

Professor of Thrombosis and Haemostasis, King’s College, London, Consultant, Departments of Haematology, Pathology and Lupus, Guy’s and St Thomas’ NHS Foundation Trust, London

Beverley Hunt is professor of thrombosis and haemostasis at King's College London and is a consultant in the departments of haematology, pathology and rheumatology. She is also deputy director of research and development at Guy's and St Thomas' Foundation Trust. Professor Hunt has clinical and research interests in thromboprophylaxis, antiphospholipid syndrome, obstetric haematology and perioperative bleeding. She is a co-founder and medical director of the thrombosis charity, ‘Lifeblood', which campaigns to raise awareness of thrombosis. Its current aim is to reduce the risk of hospital-acquired deep vein thrombosis by mandating risk assessment.

Dr Shubha Allard

Consultant Haematologist, Barts & the London NHS Trust and NHS Blood & Transplant and Honorary Clinical Senior Lecturer, Barts and the London School of Medicine, Queen Mary's University of London, London

Dr Allard is a consultant haematologist at Barts and the London NHS Trust and NHS Blood & Transplant. She is also an honorary clinical senior lecturer at Barts and the London School of Medicine, Queen Mary's University of London. She actively promotes the safe and appropriate use of blood and components at local, regional and national level. As a member of the British Committee of Standards in Haematology, she is involved in the development of national guidelines. Dr Allard is an examiner for the Royal College of Pathologists and is actively involved in postgraduate and undergraduate training together with the development of elearning tools. She is chair of the Patient and Public Involvement Group of the CMO's National Blood Transfusion Committee.